Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled Pilot Trial to Evaluate the Efficacy and Safety of Subcutaneous Abatacept in Treating Interstitial Lung Disease Associated With the Anti-synthetase Syndrome

NCT03215927 is registered in ClinicalTrials.gov with Rohit Aggarwal, MD as lead sponsor.

NCT NCT03215927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03215927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled Pilot Trial to Evaluate the Efficacy and Safety of Subcutaneous Abatacept in Treating Interstitial Lung Disease Associated With the Anti-synthetase Syndrome
Lead sponsor
Rohit Aggarwal, MD
Phase
Phase 2
Overall status
Completed
Start date
January 1, 2018
Completion date
July 30, 2023
Enrollment
20 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease, myositis